A method of diagnosing bladder cancer in a human patient comprising the steps of (i) obtaining a sample containing nucleic acid and/or protein from the bladder of a patient, preferably from the urothelium; and (ii) determining whether the sample contains a level of Pax 5 nucleic acid or protein associated with bladder cancer. A method of treating bladder cancer comprising the step of administering to the patient an agent which selectively prevents the function of Pax 5. A genetic construct comprising a nucleic acid encoding a molecule capable of preventing the function of Pax 5 expressed in a urothelial cell. The methods and compositions are particularly suited to transitional cell carcinoma of the bladder.
申请公布号
WO9963110(A1)
申请公布日期
1999.12.09
申请号
WO1999GB01720
申请日期
1999.06.01
申请人
IMPERIAL COLLEGE INNOVATIONS LIMITED;KESSLING, ANNA, MARIA;OGDEN, CHRISTOPHER, WILLIAM;ADSHEAD, JAMES;STUART, EDWARD
发明人
KESSLING, ANNA, MARIA;OGDEN, CHRISTOPHER, WILLIAM;ADSHEAD, JAMES;STUART, EDWARD